Skip to content

Comparison of side effects of antidepressants

Comparison of sexual side effects of treatment with Fluoxetine, Sertraline and Trazodone

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
IRCT
Registry ID
IRCT138810281522N3
Enrollment
102
Registered
2010-06-24
Start date
2009-12-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major depression disorder. Depressive episode

Interventions

Intervention 1: Fluoxetine 20-40mg. Intervention 2: Sertralin 50-200mg. Intervention 3: Trazodone 200-300mg.
Treatment - Drugs
Fluoxetine 20-40mg
Sertralin 50-200mg
Trazodone 200-300mg

Sponsors

Research deputy of Kermanshah University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria: major depressive disorder, being physically healthy. Exclusion criteria: concurrent active medical illness, antidepressant and anti psychotic medication for at least 5 weeks before initial study visit.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Sexual side effects. Timepoint: 8-14 weeks. Method of measurement: sexual function questionare (sfq).

Secondary

MeasureTime frame
Response to treatment. Timepoint: 4 weeks. Method of measurement: HAMILTON rating scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Habibolla Khazaie

Farabi hospital, Kermanshah university of medical science

ha_khazaie@kums.ac.ir+98 83 1826 4512

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026